JOHN SEDIVY

John Sedivy is recognized for his efforts in mammalian cell genetics, having developed and pioneered methods for gene targeting of somatic cells. In 1995 his laboratory isolated the first viable gene knockout of the Myc oncogene, and in 1997 the first homozygous gene knockout in a normal human cell. Part of his research program continues to investigate cell cycle regulation in cancer. Since 1998 his research has also focused on the biology of human aging at the cellular level. These projects currently investigate how telomere shortening as well as telomere-independent stresses cause cellular senescence.

Overview  |  Research  |  Grants/Awards  |  Teaching  |  Publications

Biography

Professor John Sedivy joined the Brown Faculty in 1996 and is a member and Chair of the Department of Molecular Biology, Cell Biology and Biochemistry. He obtained his PhD from Harvard in 1985, and subsequently trained with the Nobel Laureate Philip Sharp at the MIT Center for Cancer Research. He started his independent research career at Yale University in 1988.

John Sedivy is recognized for his efforts in mammalian genetics, having developed and pioneered methods for gene targeting of somatic cells. His research on cell cycle regulation and signal transduction, focusing on the Myc oncogene, has been continuously funded by the NIH since 1989. In 1995 his laboratory isolated the first viable gene knockouts of the c-myc oncogene, and these cell lines have become the premier model system in the Myc field. In 1997 his laboratory succeeded in isolating the first homozygous gene knockout in a normal human cell. Since 1998 his laboratory has pursued, in addition to the Myc project, studies of human replicative senescence (in vitro cell aging).

In addition to writing the first comprehensive book on gene targeting in 1992, John Sedivy has published over 90 original articles. He has served on numerous study sections and advisory committees at the NIH, the American Cancer Society, and the US Army Breast Cancer Initiative. He has consulted extensively on the genetic manipulation of mammalian cells to the biotech industry, including Biogen, Eli Lilly & Co., Abbott Laboratories, and Millenium Pharmaceuticals.

In 2000 John Sedivy became the Principal Investigator of a Center of Biomedical Research Excellence (COBRE) award from the National Center for Research Resources (NIH), an award that to date has brought over $ 22 million to Brown University over a period of 10 years. The COBRE award has been used to establish a Mouse Knockout and Transgenic Core Facility, a Genomics and Bioinformatics Core Facility, and to fund numerous pilot projects in the Division of Biology and Medicine. Most recently, John Sedivy has spearheaded the establishment of a Center for Genomics and Proteomics at Brown University, and the development of new biomedical research space in the Jewelry District of Providence.

Curricum Vitae

Download John Sedivy's Curriculum Vitae in PDF Format

JOHN SEDIVY, PHD
Herman C. Bumpus Professor of Biology and Professor of Medical Science
Molecular Biology, Cell Biology & Biochemistry
Phone: +1 401 863 9654
Phone 2: +1 401 863 7631
E-mail: John_Sedivy@Brown.EDU

John Sedivy's Brown Research URL:
http://research.brown.edu/myresearch/John_Sedivy

On The Web:
By knocking out gene p21, research team temporarily thwarts human cells' aging process
Findings about cell division yield new target for cancer drug
Research on biology of aging puts Brown on the map (GSJ of June 25, 2004)
Cellular Senescence in Aging Primates - reprint
Cellular Senescence in Aging Primates - abstract

Brown collaborators:

Are you John Sedivy? Click here to edit your research profile.

Back to search page

Research at Brown: The Directory of Research and Researchers at Brown: Research Profile
Brown.edu Brown Research home page
Contact Us Search